HEADER TRANSLATION/ANTIBIOTIC 17-JUL-12 4G5G TITLE EF-TU (ESCHERICHIA COLI) COMPLEXED WITH NVP-LDU796 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ELONGATION FACTOR TU 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: EF-TU 1, P-43; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: THIOMURACIN A DERIVATIVE; COMPND 8 CHAIN: I; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 83333; SOURCE 4 STRAIN: K12; SOURCE 5 GENE: TUFA, B3339, JW3301; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 11 ORGANISM_TAXID: 32630 KEYWDS ELONGATION FACTOR, TRANSLATION-ANTIBIOTIC COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.PALESTRANT REVDAT 3 15-NOV-23 4G5G 1 LINK ATOM REVDAT 2 13-SEP-23 4G5G 1 REMARK SEQADV SEQRES HETSYN REVDAT 2 2 1 LINK REVDAT 1 26-DEC-12 4G5G 0 JRNL AUTH M.J.LAMARCHE,J.A.LEEDS,J.DZINK-FOX,E.GANGL,P.KRASTEL, JRNL AUTH 2 G.NECKERMANN,D.PALESTRANT,M.A.PATANE,E.M.RANN,S.TIAMFOOK, JRNL AUTH 3 D.YU JRNL TITL ANTIBIOTIC OPTIMIZATION AND CHEMICAL STRUCTURE STABILIZATION JRNL TITL 2 OF THIOMURACIN A. JRNL REF J.MED.CHEM. V. 55 6934 2012 JRNL REFN ISSN 0022-2623 JRNL PMID 22812377 JRNL DOI 10.1021/JM300783C REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 21195 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.212 REMARK 3 R VALUE (WORKING SET) : 0.212 REMARK 3 FREE R VALUE : 0.258 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 952 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 21195 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3099 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 117 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : 1.600 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4G5G COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-AUG-12. REMARK 100 THE DEPOSITION ID IS D_1000073761. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-MAR-07 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 8.23 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00000 REMARK 200 MONOCHROMATOR : SI REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21195 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 1D8T REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.85 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.50 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M TRIS, 0.2M MGSO4, 24% PEG3350 , REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K, PH 8.23 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 40.15250 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 61.78850 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 40.15250 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 61.78850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 MG MG A 503 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 689 LIES ON A SPECIAL POSITION. REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE THIOMURACIN A DERIVATIVE IS OLIGOPEPTIDE, A MEMBER OF REMARK 400 ANTIBIOTIC CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: THIOMURACIN A DERIVATIVE REMARK 400 CHAIN: I REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 0 REMARK 465 ALA A 1 REMARK 465 LYS A 2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 128 C - N - CA ANGL. DEV. = 9.4 DEGREES REMARK 500 TYR I 906 CB - CG - CD2 ANGL. DEV. = -4.0 DEGREES REMARK 500 TYR I 906 CG - CD2 - CE2 ANGL. DEV. = -5.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 4 43.25 -98.69 REMARK 500 ALA A 57 -77.96 -89.35 REMARK 500 ASP A 142 75.61 -68.51 REMARK 500 GLU A 143 -13.04 -42.46 REMARK 500 ASP A 181 102.99 -53.21 REMARK 500 GLU A 215 -77.29 -107.63 REMARK 500 SER A 221 118.01 -38.78 REMARK 500 ILE A 247 -68.95 66.02 REMARK 500 ARG A 262 -1.27 74.94 REMARK 500 ARG A 333 -83.59 60.80 REMARK 500 H14 I 904 -32.77 -138.78 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 501 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR A 25 OG1 REMARK 620 2 GDP A 502 O2B 80.5 REMARK 620 3 HOH A 601 O 79.0 81.2 REMARK 620 4 HOH A 602 O 83.7 84.3 159.0 REMARK 620 5 HOH A 615 O 171.9 92.0 96.8 98.8 REMARK 620 6 HOH A 616 O 82.9 163.2 98.4 91.1 104.7 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 503 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A 653 O REMARK 620 2 HOH A 654 O 101.6 REMARK 620 3 HOH A 681 O 84.2 113.0 REMARK 620 N 1 2 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GDP A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN I OF THIOMURACIN A REMARK 800 DERIVATIVE DBREF 4G5G A 2 393 UNP P0CE47 EFTU1_ECOLI 3 394 DBREF 4G5G I 900 912 PDB 4G5G 4G5G 900 912 SEQADV 4G5G MET A 0 UNP P0CE47 EXPRESSION TAG SEQADV 4G5G ALA A 1 UNP P0CE47 EXPRESSION TAG SEQRES 1 A 394 MET ALA LYS GLU LYS PHE GLU ARG THR LYS PRO HIS VAL SEQRES 2 A 394 ASN VAL GLY THR ILE GLY HIS VAL ASP HIS GLY LYS THR SEQRES 3 A 394 THR LEU THR ALA ALA ILE THR THR VAL LEU ALA LYS THR SEQRES 4 A 394 TYR GLY GLY ALA ALA ARG ALA PHE ASP GLN ILE ASP ASN SEQRES 5 A 394 ALA PRO GLU GLU LYS ALA ARG GLY ILE THR ILE ASN THR SEQRES 6 A 394 SER HIS VAL GLU TYR ASP THR PRO THR ARG HIS TYR ALA SEQRES 7 A 394 HIS VAL ASP CYS PRO GLY HIS ALA ASP TYR VAL LYS ASN SEQRES 8 A 394 MET ILE THR GLY ALA ALA GLN MET ASP GLY ALA ILE LEU SEQRES 9 A 394 VAL VAL ALA ALA THR ASP GLY PRO MET PRO GLN THR ARG SEQRES 10 A 394 GLU HIS ILE LEU LEU GLY ARG GLN VAL GLY VAL PRO TYR SEQRES 11 A 394 ILE ILE VAL PHE LEU ASN LYS CYS ASP MET VAL ASP ASP SEQRES 12 A 394 GLU GLU LEU LEU GLU LEU VAL GLU MET GLU VAL ARG GLU SEQRES 13 A 394 LEU LEU SER GLN TYR ASP PHE PRO GLY ASP ASP THR PRO SEQRES 14 A 394 ILE VAL ARG GLY SER ALA LEU LYS ALA LEU GLU GLY ASP SEQRES 15 A 394 ALA GLU TRP GLU ALA LYS ILE LEU GLU LEU ALA GLY PHE SEQRES 16 A 394 LEU ASP SER TYR ILE PRO GLU PRO GLU ARG ALA ILE ASP SEQRES 17 A 394 LYS PRO PHE LEU LEU PRO ILE GLU ASP VAL PHE SER ILE SEQRES 18 A 394 SER GLY ARG GLY THR VAL VAL THR GLY ARG VAL GLU ARG SEQRES 19 A 394 GLY ILE ILE LYS VAL GLY GLU GLU VAL GLU ILE VAL GLY SEQRES 20 A 394 ILE LYS GLU THR GLN LYS SER THR CYS THR GLY VAL GLU SEQRES 21 A 394 MET PHE ARG LYS LEU LEU ASP GLU GLY ARG ALA GLY GLU SEQRES 22 A 394 ASN VAL GLY VAL LEU LEU ARG GLY ILE LYS ARG GLU GLU SEQRES 23 A 394 ILE GLU ARG GLY GLN VAL LEU ALA LYS PRO GLY THR ILE SEQRES 24 A 394 LYS PRO HIS THR LYS PHE GLU SER GLU VAL TYR ILE LEU SEQRES 25 A 394 SER LYS ASP GLU GLY GLY ARG HIS THR PRO PHE PHE LYS SEQRES 26 A 394 GLY TYR ARG PRO GLN PHE TYR PHE ARG THR THR ASP VAL SEQRES 27 A 394 THR GLY THR ILE GLU LEU PRO GLU GLY VAL GLU MET VAL SEQRES 28 A 394 MET PRO GLY ASP ASN ILE LYS MET VAL VAL THR LEU ILE SEQRES 29 A 394 HIS PRO ILE ALA MET ASP ASP GLY LEU ARG PHE ALA ILE SEQRES 30 A 394 ARG GLU GLY GLY ARG THR VAL GLY ALA GLY VAL VAL ALA SEQRES 31 A 394 LYS VAL LEU GLY SEQRES 1 I 13 SER BB9 ASN BB6 H14 BB9 TYR 05N BB9 BB9 MH6 BB9 NH2 MODRES 4G5G BB9 I 901 CYS MODRES 4G5G BB6 I 903 CYS (2Z)-2-AMINO-3-SULFANYLBUT-2-ENOIC ACID MODRES 4G5G H14 I 904 PHE (2S,3R)-BETA-HYDROXY-PHENYLALANINE MODRES 4G5G BB9 I 905 CYS MODRES 4G5G 05N I 907 PRO (3R,4R)-4-HYDROXY-3-METHYL-L-PROLINE MODRES 4G5G BB9 I 908 CYS MODRES 4G5G BB9 I 909 CYS MODRES 4G5G MH6 I 910 SER 3-HYDROXY-2-IMINOPROPANOIC ACID MODRES 4G5G BB9 I 911 CYS HET BB9 I 901 6 HET BB6 I 903 7 HET H14 I 904 11 HET BB9 I 905 6 HET 05N I 907 8 HET BB9 I 908 5 HET BB9 I 909 5 HET MH6 I 910 4 HET BB9 I 911 6 HET NH2 I 912 1 HET MG A 501 1 HET GDP A 502 28 HET MG A 503 1 HET SO4 A 504 5 HETNAM BB9 (2Z)-2-AMINO-3-SULFANYLPROP-2-ENOIC ACID HETNAM BB6 (2Z)-2-AMINO-3-SULFANYLBUT-2-ENOIC ACID HETNAM H14 (2S,3R)-BETA-HYDROXY-PHENYLALANINE HETNAM 05N (3R,4R)-4-HYDROXY-3-METHYL-L-PROLINE HETNAM MH6 3-HYDROXY-2-IMINOPROPANOIC ACID HETNAM NH2 AMINO GROUP HETNAM MG MAGNESIUM ION HETNAM GDP GUANOSINE-5'-DIPHOSPHATE HETNAM SO4 SULFATE ION HETSYN H14 BETA-HYDROXY-PHENYLALANINE; THREO-BETA-HYDROXY-L- HETSYN 2 H14 PHENYLALANINE; (BETAS)-BETA-HYDROXY-L-PHENYLALANINE; HETSYN 3 H14 L-THREO-3-PHENYLSERINE; L-THREO-BETA-PHENYLSERINE; 3- HETSYN 4 H14 HYDROXY-L-PHENYLALANINE FORMUL 2 BB9 5(C3 H5 N O2 S) FORMUL 2 BB6 C4 H7 N O2 S FORMUL 2 H14 C9 H11 N O3 FORMUL 2 05N C6 H11 N O3 FORMUL 2 MH6 C3 H5 N O3 FORMUL 2 NH2 H2 N FORMUL 3 MG 2(MG 2+) FORMUL 4 GDP C10 H15 N5 O11 P2 FORMUL 6 SO4 O4 S 2- FORMUL 7 HOH *117(H2 O) HELIX 1 1 GLY A 23 GLY A 40 1 18 HELIX 2 2 ALA A 45 ASN A 51 1 7 HELIX 3 3 GLY A 83 GLY A 94 1 12 HELIX 4 4 MET A 112 GLY A 126 1 15 HELIX 5 5 GLU A 144 TYR A 160 1 17 HELIX 6 6 SER A 173 GLU A 179 1 7 HELIX 7 7 ASP A 181 ILE A 199 1 19 HELIX 8 8 ARG A 204 LYS A 208 5 5 SHEET 1 A 6 SER A 65 ASP A 70 0 SHEET 2 A 6 HIS A 75 ASP A 80 -1 O HIS A 78 N VAL A 67 SHEET 3 A 6 HIS A 11 ILE A 17 1 N VAL A 14 O ALA A 77 SHEET 4 A 6 ALA A 101 ALA A 106 1 O ILE A 102 N GLY A 15 SHEET 5 A 6 ILE A 130 ASN A 135 1 O ILE A 131 N LEU A 103 SHEET 6 A 6 ILE A 169 ARG A 171 1 O VAL A 170 N VAL A 132 SHEET 1 B 2 GLU A 54 LYS A 56 0 SHEET 2 B 2 THR A 61 ASN A 63 -1 O ILE A 62 N GLU A 55 SHEET 1 C 7 LEU A 211 PRO A 213 0 SHEET 2 C 7 VAL A 291 ALA A 293 -1 O LEU A 292 N LEU A 212 SHEET 3 C 7 GLU A 241 VAL A 245 -1 N GLU A 243 O ALA A 293 SHEET 4 C 7 GLN A 251 MET A 260 -1 O GLN A 251 N ILE A 244 SHEET 5 C 7 ASN A 273 LEU A 278 -1 O LEU A 277 N GLY A 257 SHEET 6 C 7 GLY A 224 ARG A 230 -1 N VAL A 227 O VAL A 276 SHEET 7 C 7 VAL A 217 ILE A 220 -1 N PHE A 218 O VAL A 226 SHEET 1 D 5 LEU A 211 PRO A 213 0 SHEET 2 D 5 VAL A 291 ALA A 293 -1 O LEU A 292 N LEU A 212 SHEET 3 D 5 GLU A 241 VAL A 245 -1 N GLU A 243 O ALA A 293 SHEET 4 D 5 GLN A 251 MET A 260 -1 O GLN A 251 N ILE A 244 SHEET 5 D 5 LYS A 263 LEU A 265 -1 O LEU A 265 N VAL A 258 SHEET 1 E 2 ILE A 235 LYS A 237 0 SHEET 2 E 2 GLU A 267 ARG A 269 -1 O GLY A 268 N ILE A 236 SHEET 1 F 7 LYS A 299 ILE A 310 0 SHEET 2 F 7 ASN A 355 MET A 368 -1 O LEU A 362 N THR A 302 SHEET 3 F 7 THR A 335 GLU A 342 -1 N THR A 340 O THR A 361 SHEET 4 F 7 GLN A 329 PHE A 332 -1 N PHE A 330 O VAL A 337 SHEET 5 F 7 ARG A 373 GLU A 378 -1 O ALA A 375 N TYR A 331 SHEET 6 F 7 ARG A 381 GLY A 393 -1 O GLY A 386 N PHE A 374 SHEET 7 F 7 LYS A 299 ILE A 310 -1 N GLU A 305 O LYS A 390 SHEET 1 G 2 PHE A 322 PHE A 323 0 SHEET 2 G 2 MET A 349 VAL A 350 -1 O VAL A 350 N PHE A 322 LINK C SER I 900 N BB9 I 901 1555 1555 1.34 LINK C SER I 900 SG BB9 I 901 1555 1555 1.75 LINK CA SER I 900 C BB9 I 909 1555 1555 1.42 LINK CB SER I 900 CB MH6 I 910 1555 1555 1.43 LINK C BB9 I 901 N ASN I 902 1555 1555 1.35 LINK C ASN I 902 SG BB6 I 903 1555 1555 1.77 LINK C H14 I 904 N BB9 I 905 1555 1555 1.35 LINK C H14 I 904 SG BB9 I 905 1555 1555 1.76 LINK C BB9 I 905 N TYR I 906 1555 1555 1.34 LINK C TYR I 906 N 05N I 907 1555 1555 1.33 LINK C 05N I 907 N BB9 I 908 1555 1555 1.30 LINK C 05N I 907 SG BB9 I 908 1555 1555 1.76 LINK C BB9 I 908 N BB9 I 909 1555 1555 1.33 LINK C BB9 I 908 SG BB9 I 909 1555 1555 1.74 LINK C BB9 I 909 N MH6 I 910 1555 1555 1.35 LINK C MH6 I 910 N BB9 I 911 1555 1555 1.32 LINK C MH6 I 910 SG BB9 I 911 1555 1555 1.77 LINK C BB9 I 911 N NH2 I 912 1555 1555 1.33 LINK OG1 THR A 25 MG MG A 501 1555 1555 2.25 LINK MG MG A 501 O2B GDP A 502 1555 1555 2.31 LINK MG MG A 501 O HOH A 601 1555 1555 2.35 LINK MG MG A 501 O HOH A 602 1555 1555 2.41 LINK MG MG A 501 O HOH A 615 1555 1555 2.19 LINK MG MG A 501 O HOH A 616 1555 1555 2.42 LINK MG MG A 503 O HOH A 653 1555 1555 2.41 LINK MG MG A 503 O HOH A 654 1555 1555 2.33 LINK MG MG A 503 O HOH A 681 1555 1555 2.44 SITE 1 AC1 7 THR A 25 CYS A 81 GDP A 502 HOH A 601 SITE 2 AC1 7 HOH A 602 HOH A 615 HOH A 616 SITE 1 AC2 19 ASP A 21 HIS A 22 GLY A 23 LYS A 24 SITE 2 AC2 19 THR A 25 THR A 26 PHE A 46 ASN A 135 SITE 3 AC2 19 LYS A 136 ASP A 138 MET A 139 SER A 173 SITE 4 AC2 19 ALA A 174 LEU A 175 MG A 501 HOH A 601 SITE 5 AC2 19 HOH A 602 HOH A 605 HOH A 615 SITE 1 AC3 4 GLU A 152 HOH A 653 HOH A 654 HOH A 681 SITE 1 AC4 5 ARG A 262 ARG A 318 HIS A 319 THR A 320 SITE 2 AC4 5 ARG A 381 SITE 1 AC5 18 GLU A 215 THR A 228 GLY A 257 GLU A 259 SITE 2 AC5 18 PHE A 261 ARG A 262 LEU A 264 ASN A 273 SITE 3 AC5 18 VAL A 274 GLY A 275 LEU A 277 THR A 320 SITE 4 AC5 18 PRO A 321 PHE A 323 LYS A 324 HOH A 672 SITE 5 AC5 18 HOH I1001 HOH I1002 CRYST1 80.305 123.577 45.092 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012453 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008092 0.000000 0.00000 SCALE3 0.000000 0.000000 0.022177 0.00000